Aktis Oncology Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Aktis Oncology Inc in the second quarter 2026?
Aktis Oncology Inc recorded a cumulative net loss of $-76 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -38.75%.

Within the Consumer Electronics industry 26 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 3492, from total ROE ranking in the first quarter 2026 at 3499.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Sep 30 2024) I. Quarter
Y / Y Equity Change	-	1107.75 %	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-76	-58	-69	-74	-75
Return On Equity (TTM)	-38.75 %	-97.29 %	-	-	-281.5 %
AKTS's Total Ranking	# 3492	# 3499	#	#	#
Equity (TTM) in Millions	485	506	-146	-65	-57
Seq. Equity Change	-4.2 %	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to AKTS Management Effectiveness >> AKTS's 5 Years Annual ROE >> Compare AKTS ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 27
Sector	# 424
Overall	# 3492

Return On Equity Statistics
High	Average	Low
-38.75 %	-109.87 %	-333.05 %
(Jun 30 2026)		(Jun 30 2024)

AKTS Annual Return On Equity	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022	(Jun 30 2021) 2021	(Jun 30 2020) 2020
Total Equity in Millions	-57	86	103	117	41
Y / Y Equity Change	-	-16.62 %	-11.91 %	182.95 %	59.87 %
Net Income in Millions	-168	-64	-59	-44	-36
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-73.7 %	-57.23 %	-37.61 %	-87.09 %

Back to AKTS Management Effectiveness >> AKTS's 5 Years Annual ROE >> Compare AKTS ROE to its Competitors

More Return On Equity Ratios
Consumer Electronics Industry Roe Trends and Statistics
Technology Sector Return On Equity Statistics
AKTS's' Return on Equity at Yahoo Finance
AKTS's Roe Ratio versus Consumer Electronics Industry, Technology Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AKTS's Competitors
Subscribers only: Roe for Aktis Oncology Inc 's Suppliers
Subscribers only: Return On Equity for AKTS's Customers

Companies with similar Return On Equity at Jun 30 2026, within Technology Sector

ROE

Date modified: 2026-09-26T07:43:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.